AngioDynamics designs and sells minimally invasive medical devices used in vascular and oncology procedures. Its portfolio includes tools such as the Auryon laser atherectomy system for peripheral arterial disease, the AlphaVac system for large-vessel clot removal, and the NanoKnife irreversible electroporation system for soft-tissue ablation. Hospitals and specialists use these products to restore blood flow, treat thrombi, and expand options in solid-tumor care.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 80.2 | — | -6 | — |
| Q3 2025 | 75.7 | — | -10.9 | — |
| Q4 2025 | 79.4 | — | -6.3 | — |
| Q1 2026 | 78.4 | — | -8.1 | — |
| Q2 2026 | 86.6 | 8.1% | -11.4 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: AMERISAFE, Inc. (AMSF), Private Bancorp of America, Inc. (PBAM), Gores Holdings X, Inc. (GTEN), Evolus, Inc. (EOLS), Euroseas Ltd. (ESEA), Apex Treasury Corporation (APXT)